Mannose-containing oligosaccharides of non-specific human secretory immunoglobulin a mediate inhibition of Vibrio cholerae biofilm formation

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Murthy, Ashlesh K ^a   Chaganty, Bharat K R ^a   Troutman, Ty ^a   Guentzel, M Neal ^a   Yu, Jieh Juen ^a   Ali, Syed Khalid ^a   Lauriano, Crystal M ^a   Chambers, James P ^a   Klose, Karl E ^a   Arulanandam, Bernard P ^a  

^a Texas Center for Infectious Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLYCOSIDASE H; GLYCOSIDASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MANNOSE OLIGOSACCHARIDE; SECRETORY IMMUNOGLOBULIN; UNCLASSIFIED DRUG; MANNOSE; OLIGOSACCHARIDE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIABILITY; BACTERIAL VIRULENCE; BIOFILM; CHOLERA; CONTROLLED STUDY; DISEASE PREDISPOSITION; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; MOUSE; NONHUMAN; PHENOTYPE; VIBRIO CHOLERAE; ANIMAL; CHEMISTRY; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTESTINE; METABOLISM; MICROBIOLOGY; MILK; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); MUS; VIBRIO CHOLERAE;

ANIMALS; BIOFILMS; FEMALE; HUMANS; IMMUNOGLOBULIN A, SECRETORY; INTESTINES; MANNOSE; MICE; MILK; OLIGOSACCHARIDES; VIBRIO CHOLERAE;

EID: 79951788066     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016847     Document Type: Article

References (43)

1. Brandtzaeg P, (2009) Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol 70: 505-515.
2. van der Heijden PJ, Stok W, Bianchi AT, (1987) Contribution of immunoglobulin-secreting cells in the murine small intestine to the total 'background' immunoglobulin production. Immunology 62: 551-555.
3. Kaetzel CS, (2001) Polymeric Ig receptor: defender of the fort or Trojan horse? Curr Biol 11: R35-R38.
4. Mestecky J, McGhee JR, (1987) Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 40: 153-245.
5. Kerr MA, (1990) The structure and function of human IgA. Biochem J 271: 285-296.
6. Cunningham-Rundles C, (2001) Physiology of IgA and IgA deficiency. J Clin Immunol 21: 303-309.
7. Woof JM, Kerr MA, (2006) The function of immunoglobulin A in immunity. J Pathol 208: 270-282.
8. Lamm ME, Robinson JK, Kaetzel CS, (1992) Transport of IgA immune complexes across epithelial membranes: new concepts in mucosal immunity. Adv Exp Med Biol 327: 91-94.
9. Mestecky J, Russell MW, Elson CO, (1999) Intestinal IgA: novel views on its function in the defence of the largest mucosal surface. Gut 44: 2-5.
10. Mazanec MB, Kaetzel CS, Lamm ME, Fletcher D, Nedrud JG, (1992) Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci USA 89: 6901-6905.
11. Lamm ME, (1997) Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol 51: 311-340.
12. Mason KL, Huffnagle GB, Noverr MC, Kao JY, (2008) Overview of gut immunology. Adv Exp Med Biol 635: 1-14.
13. Murthy AK, Dubose CN, Banas J, Coalson JJ, Arulanandam BP, (2006) Contribution of polymeric immunoglobulin receptor to regulation of intestinal inflammation in dextran sulfate sodium-induced colitis. J Gastroenterol Hepatol 21: 1372-1380.
14. Corthesy B, (2010) Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces. Future Microbiol 5: 817-829.
15. Royle L, Roos A, Harvey DJ, Wormald MR, van Gijlswijk-Janssen D, et al. (2003) Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J Biol Chem 278: 20140-20153.
16. Faruque SM, Albert MJ, Mekalanos JJ, (1998) Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev 62: 1301-1314.
17. Donlan RM, Costerton JW, (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193.
18. Watnick PI, Kolter R, (1999) Steps in the development of a Vibrio cholerae El Tor biofilm. Mol Microbiol 34: 586-595.
19. Yildiz FH, Schoolnik GK, (1999) Vibrio cholerae O1 El Tor: identification of a gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation. Proc Natl Acad Sci USA 96: 4028-4033.
20. Faruque SM, Biswas K, Udden SM, Ahmad QS, Sack DA, et al. (2006) Transmissibility of cholera: in vivo-formed biofilms and their relationship to infectivity and persistence in the environment. Proc Natl Acad Sci USA 103: 6350-6355.
21. Colwell RR, Huq A, Islam MS, Aziz KM, Yunus M, et al. (2003) Reduction of cholera in Bangladeshi villages by simple filtration. Proc Natl Acad Sci USA 100: 1051-1055.
22. Waldor MK, Mekalanos JJ, (1994) ToxR regulates virulence gene expression in non-O1 strains of Vibrio cholerae that cause epidemic cholera. Infect Immun 62: 72-78.
23. Guentzel MN, Berry LJ, (1974) Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens. Infect Immun 10: 167-172.
24. Yildiz FH, Visick KL, (2009) Vibrio biofilms: so much the same yet so different. Trends Microbiol 17: 109-118.
25. Nesper J, Lauriano CM, Klose KE, Kapfhammer D, Kraiss A, et al. (2001) Characterization of Vibrio cholerae O1 El tor galU and galE mutants: influence on lipopolysaccharide structure, colonization, and biofilm formation. Infect Immun 69: 435-445.
26. Lauriano CM, Ghosh C, Correa NE, Klose KE, (2004) The sodium-driven flagellar motor controls exopolysaccharide expression in Vibrio cholerae. J Bacteriol 186: 4864-4874.
27. Tomana M, Mestecky J, Niedermeier W, (1972) Studies on human secretory immunoglobulin A. IV. Carbohydrate composition. J Immunol 108: 1631-1636.
28. Guentzel MN, Field LH, Eubanks ER, Berry LJ, (1977) Use of fluorescent antibody in studies of immunity to cholera in infant mice. Infect Immun 15: 539-548.
29. Eubanks ER, Guentzel MN, Berry LJ, (1977) Evaluation of surface components of Vibrio cholerae as protective immunogens. Infect Immun 15: 533-538.
30. Guentzel MN, Berry LJ, (1975) Motility as a virulence factor for Vibrio cholerae. Infect Immun 11: 890-897.
31. Guentzel MN, Amerine D, Guerrero D, Gay TV, (1981) Association of Vibrio cholerae mutants with the intestinal mucosa of infant mice. Scan Electron Microsc 4: 115-124.
32. Bishop AL, Schild S, Patimalla B, Klein B, Camilli A, (2010) Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by anti-lipopolysaccharide antibodies that inhibit bacterial motility. Infect Immun 78: 4402-4420.
33. Giugliano LG, Ribeiro ST, Vainstein MH, Ulhoa CJ, (1995) Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli. J Med Microbiol 42: 3-9.
34. Camara LM, Carbonare SB, Scaletsky IC, da Silva ML, Carneiro-Sampaio MM, (1995) Inhibition of enteropathogenic Escherichia coli (EPEC) adherence to HeLa cells by human colostrum. Detection of specific SIgA related to EPEC outer-membrane proteins. Adv Exp Med Biol 371A: 673-676.
35. Perrier C, Sprenger N, Corthesy B, (2006) Glycans on secretory component participate in innate protection against mucosal pathogens. J Biol Chem 281: 14280-14287.
36. Hooper LV, Macpherson AJ, (2010) Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 10: 159-169.
37. Nikolova EB, Tomana M, Russell MW, (1994) All forms of human IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or by antigen alone. Scand J Immunol 39: 275-280.
38. Russell MW, Reinholdt J, Kilian M, (1989) Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation. Eur J Immunol 19: 2243-2249.
39. Flajnik MF, (2010) All GOD's creatures got dedicated mucosal immunity. Nat Immunol 11: 777-779.
40. Hsiao A, Liu Z, Joelsson A, Zhu J, (2006) Vibrio cholerae virulence regulator-coordinated evasion of host immunity. Proc Natl Acad Sci U S A 103: 14542-14547.
41. Dallas SD, Rolfe RD, (1998) Binding of Clostridium difficile toxin A to human milk secretory component. J Med Microbiol 47: 879-888.
42. Clark JA, Callicoat PA, Brenner NA, Bradley CA, Smith DA Jr, (1983) Selective IgA deficiency in blood donors. Am J Clin Pathol 80: 210-213.
43. Harriman GR, Bogue M, Rogers P, Finegold M, Pacheco S, et al. (1999) Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes. J Immunol 162: 2521-2529.